Search research articles
Contact Us
Filters
Showing results (371-380 of 688) with videos related to
Page
of 69
Sort By:
Journal of the American College of Cardiology
|
August 3, 2019
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Awais Malik, Ravi Masson, Steven Singh, et al.
Journal of Clinical Pharmacology
|
April 13, 2018
An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675
Bertram Pitt, Vanessa Zann, Chris Roe, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 10, 2009
Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction
Scott D Solomon, Anil Verma, Akshay Desai, et al.
JACC. Advances
|
February 28, 2025
Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITY
Ajay K Singh, Glen James, Stefan D Anker, et al.
The American Journal of Cardiology
|
August 18, 2014
Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH Study)
Alan Maisel, Yang Xue, Dirk J van Veldhuisen, et al.
European Heart Journal
|
June 2, 2021
What can heart failure trialists learn from oncology trialists?
Faiez Zannad, Gad Cotter, Angeles Alonso Garcia, et al.
Biorxiv : the Preprint Server for Biology
|
December 11, 2025
Targeting Metabolic Dysfunction and Inflammation with Sotagliflozin Reverses Diastolic Dysfunction in Experimental HFpEF
Parisa Shabani, Tahra Luther, Rajesh Chaudhary, et al.
The American Journal of Cardiology
|
April 11, 2020
Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)
Marat Fudim, Jacob P Kelly, Todd J Brophy, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 9, 2021
Impact of donor blood type on outcomes after prolonged allograft ischemic times
Paul C Tang, Jonathan W Haft, Ienglam Lei, et al.
European Heart Journal
|
January 5, 2011
Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data
Gerasimos S Filippatos, Mustafa I Ahmed, James D Gladden, et al.
Page
of 69
Search research articles
Search
Showing results (371-380 of 688) with videos related to
Sort By:
Page
of 69
Journal of the American College of Cardiology
|
August 3, 2019
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Awais Malik, Ravi Masson, Steven Singh, et al.
Journal of Clinical Pharmacology
|
April 13, 2018
An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675
Bertram Pitt, Vanessa Zann, Chris Roe, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 10, 2009
Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction
Scott D Solomon, Anil Verma, Akshay Desai, et al.
JACC. Advances
|
February 28, 2025
Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITY
Ajay K Singh, Glen James, Stefan D Anker, et al.
The American Journal of Cardiology
|
August 18, 2014
Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH Study)
Alan Maisel, Yang Xue, Dirk J van Veldhuisen, et al.
European Heart Journal
|
June 2, 2021
What can heart failure trialists learn from oncology trialists?
Faiez Zannad, Gad Cotter, Angeles Alonso Garcia, et al.
Biorxiv : the Preprint Server for Biology
|
December 11, 2025
Targeting Metabolic Dysfunction and Inflammation with Sotagliflozin Reverses Diastolic Dysfunction in Experimental HFpEF
Parisa Shabani, Tahra Luther, Rajesh Chaudhary, et al.
The American Journal of Cardiology
|
April 11, 2020
Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)
Marat Fudim, Jacob P Kelly, Todd J Brophy, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 9, 2021
Impact of donor blood type on outcomes after prolonged allograft ischemic times
Paul C Tang, Jonathan W Haft, Ienglam Lei, et al.
European Heart Journal
|
January 5, 2011
Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data
Gerasimos S Filippatos, Mustafa I Ahmed, James D Gladden, et al.
Page
of 69